The state of HTS automation: comparing integrated robotics and workstations
Michael L. Biros
(Michael L. Biros is Marketing Director, Molecular Devices, 1311 Orleans Drive, Sunnyvale, California, USA)
211
Abstract
Compares the various features and advantages of using integrated robotic systems or dedicated workstations for drug discovery. Also describes hybrid systems. Provides guidance on the criteria for system selection.
Keywords
Citation
Biros, M.L. (2002), "The state of HTS automation: comparing integrated robotics and workstations", Industrial Robot, Vol. 29 No. 1, pp. 38-42. https://doi.org/10.1108/01439910210413705
Publisher
:MCB UP Ltd
Copyright © 2002, MCB UP Limited